FIELD: organic chemistry. SUBSTANCE: invention proposes derivatives of hydroxamic acid of the formula (I): HO-NH-CO-CH(OH)-CHR2-C(O)-NH-CHR3C(O)N-R4R5 where R2 is C1-C6-alkyl; R3 is C1-C6-alkyl or R7 is -B-; n = 0, 1; B is divalent C1-C6-alkyl; R7 is CO-NH-OH, cycloalkyl, 5-6-membered heterocycle containing N or S as heteroatom, phenyl, phenyl-substituted phenyl; R4 is H, CH3; R5 is C1-C6-alkyl possibly substituted with heterocycle, or R3 and R5 form together divalent C8-C14-radical. Indicated compounds are synthesized by interaction of compound HCOO-CH(OH)--CHR2--C(O)-NH--CR3H--C(O)-N-R4R5 with hydroxylamine. Compounds of the formula (I) show inhibition effect with respect to metalloproteinase activity and tumor necrosis factor formation and can be used in the corresponding pharmaceutical composition. EFFECT: improved method of synthesis, enhanced effectiveness of compounds. 21 cl, 10 ex
Title | Year | Author | Number |
---|---|---|---|
DERIVATIVES OF HYDROXAMIC OR CARBOXYLIC ACID AND PHARMACEUTICAL OR VETERINARY COMPOSITION ON SAID | 1995 |
|
RU2136657C1 |
ANTIBACTERIAL AGENT | 2000 |
|
RU2269525C2 |
CYTOSTATIC AGENTS | 1998 |
|
RU2187499C2 |
N-[2,2-DIMETHYL-1S-(PYRIDIN-2-YL-CARBAMOYL)-PROPYL]-N-HYDROXY-2R-ISOBUTYL-3S-METHOXYSUCCIN-AMIDE OR ITS PHARMACEUTICALLY ACCEPTABLE SALT, HYDRATE OR SOLVATE | 1997 |
|
RU2198164C2 |
ISOINDOLINE DERIVATIVE, INTERMEDIATE PRODUCT, METHOD OF PRODUCING, PHARMACEUTICAL COMPOSITION AND USE THEREOF | 2015 |
|
RU2695521C2 |
ANTIBACTERIAL AGENTS | 1999 |
|
RU2246941C2 |
ANDROGEN RECEPTOR MODULATORS AND METHODS FOR THEIR USE | 2019 |
|
RU2797622C2 |
TAXOL DERIVATIVES WITH ANTICANCER ACTIVITY | 2007 |
|
RU2419622C2 |
PHENYLPYRAZOL DERIVATIVES | 2008 |
|
RU2480456C2 |
ANTITUMOR EFFECT ENHANCER USING NEW BIPHENYL COMPOUND | 2018 |
|
RU2765153C2 |
Authors
Dates
1999-02-27—Published
1993-07-23—Filed